✦ LIBER ✦

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

✍ Scribed by Tomaso Prayer-Galetti; Emilio Sacco; Francesco Pagano; Marina Gardiman; Antonio Cisternino; Giovanni Betto; Paolo Sperandio

Book ID: 109053134
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 148 KB
Volume: 100
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2007.06760.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib